deCode Announces Lupus Gene Agreement with Pfizer

deCODE genetics, headquartered in Reykjavik, Iceland, yesterday announced that they had entered into a research partnership with Pfizer.  The collaboration will seek to discover “sequence variants associated with specific clinical phenotypes related to systemic lupus erythematosis by utilizing the Reykjavik-based firm’s expertise in gene discovery”. Over the next 18 months, deCODE and Pfizer will work

Continue Reading